Core Viewpoint - ScanTech AI Systems Inc. is facing potential delisting from Nasdaq due to non-compliance with listing requirements, specifically regarding market value and periodic filing obligations [2][3]. Group 1: Nasdaq Compliance Issues - On February 4, 2026, ScanTech AI received a deficiency notice from Nasdaq indicating that its market value of publicly held shares (MVPHS) was below the required $15 million for 30 consecutive business days [2]. - The company has a 180-day compliance period until August 3, 2026, to regain compliance by maintaining an MVPHS of at least $15 million for ten consecutive business days [2]. - On February 6, 2026, the Nasdaq Hearing Panel denied the company's request for continued listing, citing non-compliance with Nasdaq Listing Rules 5250(c)(1) and 5450(b)(2)(A) [3]. Group 2: Next Steps and Alternatives - The company has 15 days from the receipt of the determination letter to request a review of the Panel's decision by the Nasdaq Listing and Hearing Review Council [4]. - ScanTech AI is evaluating options, including submitting a request for review, which could lead to various outcomes such as affirmation or reversal of the Panel's decision [4]. - Concurrently, the company plans to apply for its common stock to be quoted on the OTCQB Venture Market, although there is no guarantee of meeting eligibility requirements [5]. Group 3: Company Overview - ScanTech AI Systems Inc. specializes in advanced AI-powered security screening and imaging technologies, particularly in non-intrusive 'fixed-gantry' CT screening [6]. - The company's technology is designed to detect hazardous materials and contraband, with applications in various high-security environments such as airports, seaports, and government buildings [6].

Sterling Capital Management launched the Sterling Capital Hedged Equity Premium Income ETF (SCEP) last year. The actively managed fund uses artificial intelligence for idea generation, and human intelligence for portfolio construction to deliver a best ideas U.S. equity allocation, while employing options strategies to generate income and protect against market drops, according to Whitney Stewart, executive director at Sterling Capital. The fund, which began trading December 12 and currently manages $214.1 ...

Key Takeaways NBIS will report Q4 results Feb. 12, with the consensus implying a 44-cent loss and $232.2 million in revenue.Nebius is scaling its AI cloud with new platform releases and expanded global data center capacity.NBIS began contributions from Microsoft and Meta contracts in Q4, while facing heavy capex and supply woes.Nebius Group N.V. (NBIS) will report fourth-quarter 2025 results on Feb. 12, before market open.The Zacks Consensus Estimate for the bottom line for the to-be-reported quarter is peg ...

Perros reported fourth quarter revenue of $335 million , with Fee Revenue Less Production Costs (FRLPC) of $131 million and adjusted EBITDA of $98 million , representing a 29% adjusted EBITDA margin . He said FRLPC was 4.9% of network volume , which management framed as strong monetization while remaining disciplined on risk.CFO Evangelos Perros said the financial results reflected work over multiple years to strengthen Pagaya’s operating model, capital structure, and data and risk infrastructure. He added ...

One Stop Systems Inc. (NASDAQ:OSS) is one of the hidden AI stocks under $10 to buy. On January 5, Alliance Global raised its price target for One Stop Systems to $9 from $8.50 while keeping a Buy rating following the company’s $22.4 million sale of its European value-added reseller, Bressner Technology, to Hiper Euro. The firm noted the sale price exceeded expectations and characterized the divested business as a minimal contributor to shareholder value due to its very low contribution margin. Consequent ...

Azitra Announces Adjournment of Special Meeting and Information for Reconvened Special Meeting [Accessibility Statement] Skip NavigationBRANFORD, Conn., Feb. 6, 2026 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced its Special Meeting scheduled for and convened on February 6, 2026, (the "Special Meeting") has been adjourned until March 6, 2026, at 11:00 a.m. Eastern Time (the " ...

Samuel Smith has a diverse background that includes being lead analyst and Vice President at several highly regarded dividend stock research firms and running his own dividend investing YouTube channel. He is a Professional Engineer and Project Management Professional and holds a B.S. in Civil Engineering & Mathematics from the United States Military Academy at West Point and has a Masters in Engineering with a focus on applied mathematics and machine learning. Samuel leads the High Yield Investor investing ...

th– Live video webcast on Tuesday, February 10 at 1:20 PM EST â"¢ Decoy Therapeutics is a preclinical-stage biotechnology company that is leveraging ML and AI tools alongside high-speed synthesis techniques to rapidly design, engineer and manufacture peptide conjugate drug candidates that target serious unmet medical needs. The company's initial pipeline is focused on respiratory viruses and GI cancers. Decoy has attracted financing from institutional investors as well as significant non-dilutive capital fr ...

Access the "What This Means" segment here CAMBRIDGE, Mass. and HOUSTON, Feb. 4, 2026 /PRNewswire/ -- Decoy Therapeutics, Inc. (Nasdaq: DCOY) (Decoy, or the Company), a preclinical biopharmaceutical that is engineering the next generation of peptide conjugate therapeutics, today announced that it participated in a Virtual Investor "What This Means" segment highlighting the Company's recently announced Global Access Commitment Agreement (GACA) with the Gates Foundation. The "What This Means" segment provides ...

Enact (NasdaqGS:ACT) Q4 2025 Earnings call February 04, 2026 08:00 AM ET Company ParticipantsBose George - Managing DirexctorDaniel Kohl - Head of Investor RelationsDean Mitchell - CFORohit Gupta - CEOConference Call ParticipantsDouglas Harter - Director and Equity AnalystMihir Bhatia - Stock Analyst and Equity ResearchRichard Shane - AnalystOperatorHello, and thank you for standing by. Welcome to Enact Fourth Quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode. A ...